In vitro effects of melatonin on cell proliferation in a colon adenocarcinoma line

Journal of Applied Toxicology

Volumn 20, Issue 1, 2000, Pages 21-24

  Farriol, M ^a   Venereo, Y ^a   Orta, X ^a   Castellanos, J M ^a   Segovia Silvestre, T ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Cancer; Colon; CT 26; Melatonin

Indexed keywords

ESTRADIOL RECEPTOR; LACTATE DEHYDROGENASE; MELATONIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; COLON ADENOCARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOCARCINOMA; ANIMALS; CELL DIVISION; COLONIC NEOPLASMS; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; L-LACTATE DEHYDROGENASE; MELATONIN; MICE; RECEPTORS, ESTRADIOL; TUMOR CELLS, CULTURED;

MURINAE;

EID: 0033951733     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1263(200001/02)20:1<21::AID-JAT623>3.0.CO;2-M     Document Type: Article

References (23)

1. C. M. Cagnoli, C. Atabay, E. Kharlanova and H. Manev, Melatonin protects neurons from singlet oxygen-induced apoptosis. J Pineal Res. 18, 222-228 (1995).
2. R. L. Sack, A. J. Lewy, D. L. Erb, W. M. Vollmer and C. M. Singer, Human melatonin production decreases with age. J. Pineal Res. 3, 379-388 (1986).
3. P. Lissoni, F. Brivio, O. Brivio, et al., Immune effects of preoperative immunotherapy with high-dose subcutaneous interleukin-2 versus neuroimmunotherapy with low-dose interleukin-2 plus the neurohormone melatonin in gastrointestinal tract tumor patients. J. Biol. Regul. Homeost. Agents 9, 31-33 (1995).
4. S. Cos and E. J. Sanchez-Barcelo, Melatonin inhibition of MCF-7 human breast-cancer cells growth: influence of cell proliferation rate. Cancer Lett. 85, 207-212 (1995).
5. F. Lopez Muñoz, J. Boya, F. Marin and J. L. Calvo, Scientific research on the pineal gland and melatonin: a bibliometric study for the period 1966-1994. J Pineal Res. 20, 115-124 (1996).
6. S. Cos, R. Verduga, C. Femandez-Viadero, M. Megias and D. Crespo, Effects of melatonin on the proliferation and differentiation of human neuroblastoma cells in culture. Neurosci. Lett. 216, 113-116 (1996).
7. D. N. Hu and J. E. Roberts, Melatonin inhibits growth of cultured human uveal melanoma. Melanoma Res. 7, 27-31 (1997).
8. G. Melen-Mucha, K. Winczyk and M. Pawlikowski, Somatostatin analogue ocreotide and melatonin inhibit bromodeoxyuridine incorporation into cell nuclei and enhance apoptosis in the transplantable murine colon 38 cancer. Antic. Res. 18, 3615-3620 (1998).
9. E. Nasatzy, Z. Schwartz, W. A. Soskolne, et al. Evidence for receptors specific for 17 beta-estradiol and testosterone in chondrocyte cultures. Connective Tissue Res. 30, 277-294 (1994).
10. R. Mira-Lopez and L. Ossowski, Preservation of steroid hormone receptors in organ cultures of human breast carcinomas. Cancer Res. 50, 78-83 (1990).
11. B. R. Westley and F. E. B. May, In vitro development of tamoxifen resistance. In Endocrine-related Cancer, ed. by V. H. T. James, Vol. 2. Journal of Endocrinology Ltd (1995).
12. M. G. Brattain, J. Strobel-Stevens, D. Fine, M. Webb and A. M. Sarrif, Establishment of mouse colonic carcinoma cell lines with different metastatic properties. Cancer Res. 40, 2142-2146 (1980).
13. J. L. Wittiff and E. D. Saulor, Estrogen-binding capacity of cytoplasmatic forms of the estrogen receptors in human breast cancer. In Estrogen Receptors in Human Breast Cancer, ed. by W. L. McGuire, P. P Carbone and E. P. Wollmer. Raven Press, New York, 63-72 (1975).
14. M. A. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of dye binding. Anal. Biochem. 72, 224-254 (1976).
15. T. Porstmann, T. Temynck and S. Avrameas, Quantitation of 5-bromo-2-deoxyuridine incorporation into DNA: an enzyme immunoassay for the assessment of lymphoid cell proliferative response. J. Immunol. Methods 82, 169-179 (1985).
16. C. G. Fraser, P. Hyltoft Petersen, C. Ricos and R. Haeckel, Proposed quality specifications for the imprecision and inaccuracy of analytical systems for clinical chemistry. Eur. J. Clin. Chem. Clin. Biochem. 30, 311-317 (1992).
17. A. Panzer, M. L. Lottering, P. Bianchi, D. K. Glencross, J. H. Starrk and J. C. Seegers, Melatonin has no effect on the growth, morphology or cell cycle of human breast cancer (MCF-7), cervical cancer (HeLa), osteosarcoma (MG-63) or lymphoblastoid (TK6) cells. Cancer Lett. 122, 17-23 (1998).
18. S. M. Hill and D. E. Blask, Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res. 48, 6121-6126 (1988).
19. M. A. Pahlavani, Role of melatonin in immunity, aging and cancer: therapeutic intervention. Drugs Today 33, 25-39 (1997).
20. R. A. Helton, W. A. Harrison, K. Kelley and M. A. Kane, Melatonin interactions with cultured murine B16 melanoma cells. Melanoma Res. 3, 403-413 (1993).
21. P. T. Ram, T. Kiefer, M. Silverman, Y. Song, G. M. Brown and S. M. Still. Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors. Mol. Cell. Endocrinol. 141, 53-64 (1998).
22. 1b melatonin receptor. Proc. Natl. Acad. Sci. USA 92, 8734-8738 (1995).
23. A. M. Poon, P. H. Chow, A. S. Mak and S. F. Pang, Autoradiographic localization of 2[1251] iodomelatonin binding sites in the gastrointestinal tract of mammals including humans and birds. J. Pineal Res. 23, 5-14 (1997).